Photronics Reports Third Quarter Fiscal 2025 Financial Results
Commenting on the third-quarter performance, Chairman and CEO
Third Quarter Fiscal 2025 Results
- Revenue was
$210.4 million , down 0.3% year-over-year and 0.3% sequentially. - GAAP Net income attributable to
Photronics, Inc. shareholders was$22.9 million , or$0.39 per diluted share, compared with$34.4 million , or$0.55 per diluted share, in the third quarter of 2024 and$8.9 million , or$0.15 per diluted share, in the second quarter of 2025. - Non-GAAP Net income attributable to
Photronics, Inc. shareholders was$29.4 million , or$0.51 per diluted share, compared with$31.9 million , or$0.51 per diluted share in the third quarter of 2024 and$24.3 million , or$0.40 per diluted share, in the second quarter of 2025. - IC revenue was
$147.8 million , down 5% year-over-year and 5% sequentially. - FPD revenue was
$62.6 million , up 14% from the same quarter last year and 14% sequentially. - Cash, cash equivalents and short-term investments at the end of the quarter were
$575.8 million , of which$396.8 million was associated with our Joint Ventures, of which we own 50%. - Cash generated from operating activities was
$50.1 million , cash invested in organic growth through capital expenditures was$24.8 million , and cash returned to shareholders through share repurchases was$20.7 million . - The Board of Directors authorized an increase of
$25.0 million to the share repurchase authorization.
Fourth Quarter Fiscal 2025 Guidance
For the fourth quarter of fiscal 2025, Photronics expects Revenue to be between
Webcast
A webcast to discuss these results is scheduled for
About Photronics
Photronics is a leading worldwide manufacturer of integrated circuit (IC) and flat panel display (FPD) photomasks. High precision quartz plates that contain microscopic images of electronic circuits, photomasks are a key element in the IC and FPD manufacturing process. Founded in 1969, Photronics has been a trusted photomask supplier for over 56 years. The company operates 11 strategically located manufacturing facilities in
Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements” regarding our industry, our strategic position, and our financial and operating results. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, performance or achievements to differ materially. Please refer to Item 1A “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
Non-GAAP Net Income attributable to
| Condensed Consolidated Statements of Income | ||||||||||||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||
| 2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||
| Revenue | $ | 210,394 | $ | 210,992 | $ | 210,984 | $ | 633,524 | $ | 644,318 | ||||||||||||
| Cost of goods sold | 139,539 | 133,086 | 135,846 | 409,228 | 410,674 | |||||||||||||||||
| Gross Profit | 70,855 | 77,906 | 75,138 | 224,296 | 233,644 | |||||||||||||||||
| Gross margin % | 33.7 | % | 36.9 | % | 35.6 | % | 35.4 | % | 36.3 | % | ||||||||||||
| Operating Expenses: | ||||||||||||||||||||||
| Selling, general and administrative | 18,423 | 18,099 | 19,436 | 55,624 | 56,753 | |||||||||||||||||
| Research and development | 4,271 | 4,090 | 3,555 | 12,618 | 11,291 | |||||||||||||||||
| Total Operating Expenses | 22,694 | 22,189 | 22,991 | 68,242 | 68,044 | |||||||||||||||||
| Other operating gain | - | - | 1 | - | 90 | |||||||||||||||||
| Operating Income | 48,161 | 55,717 | 52,148 | 156,054 | 165,690 | |||||||||||||||||
| Operating Margin | 22.9 | % | 26.4 | % | 24.7 | % | 24.6 | % | 25.7 | % | ||||||||||||
| Non-operating (loss) income, net | (9,428 | ) | (25,786 | ) | 10,145 | (10,232 | ) | 26,931 | ||||||||||||||
| Income Before Income Tax Provision | 38,733 | 29,931 | 62,293 | 145,822 | 192,621 | |||||||||||||||||
| Income tax provision | 9,594 | 5,714 | 14,124 | 34,209 | 48,998 | |||||||||||||||||
| Net Income | 29,139 | 24,217 | 48,169 | 111,613 | 143,623 | |||||||||||||||||
| Net income attributable to noncontrolling interests | 6,248 | 15,356 | 13,781 | 37,009 | 46,804 | |||||||||||||||||
| Net income attributable to |
$ | 22,891 | $ | 8,861 | $ | 34,388 | $ | 74,604 | $ | 96,819 | ||||||||||||
| Earnings per share attributed to |
||||||||||||||||||||||
| Basic | $ | 0.40 | $ | 0.15 | $ | 0.56 | $ | 1.24 | $ | 1.57 | ||||||||||||
| Diluted | $ | 0.39 | $ | 0.15 | $ | 0.55 | $ | 1.23 | $ | 1.55 | ||||||||||||
| Weighted-average number of common shares outstanding: | ||||||||||||||||||||||
| Basic | 57,937 | 60,793 | 61,815 | 60,274 | 61,681 | |||||||||||||||||
| Diluted | 58,068 | 60,974 | 62,414 | 60,567 | 62,369 | |||||||||||||||||
| Condensed Consolidated Balance Sheets | |||||||||
| (in thousands) | |||||||||
| (Unaudited) | |||||||||
| 2025 | 2024 | ||||||||
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 479,521 | $ | 598,485 | |||||
| Short-term investments | 96,277 | 42,184 | |||||||
| Accounts receivable | 190,875 | 200,830 | |||||||
| Inventories | 63,490 | 56,527 | |||||||
| Other current assets | 42,073 | 33,036 | |||||||
| Total current assets | 872,236 | 931,062 | |||||||
| Property, plant and equipment, net | 838,988 | 745,257 | |||||||
| Other assets | 41,541 | 35,740 | |||||||
| Total assets | $ | 1,752,765 | $ | 1,712,059 | |||||
| Liabilities and Equity | |||||||||
| Current liabilities: | |||||||||
| Current portion of long-term debt | $ | 11 | $ | 17,972 | |||||
| Accounts payable and accrued liabilities | 174,914 | 165,839 | |||||||
| Total current liabilities | 174,925 | 183,811 | |||||||
| Long-term debt | 16 | 25 | |||||||
| Other liabilities | 39,824 | 47,464 | |||||||
| Equity: | |||||||||
| 1,125,551 | 1,120,864 | ||||||||
| Noncontrolling interests | 412,449 | 359,895 | |||||||
| Total equity | 1,538,000 | 1,480,759 | |||||||
| Total liabilities and equity | $ | 1,752,765 | $ | 1,712,059 | |||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||
| (in thousands) | ||||||||||||
| (Unaudited) | ||||||||||||
| Nine Months Ended | ||||||||||||
| 2025 | 2024 | |||||||||||
| Cash flows from operating activities: | ||||||||||||
| Net income | $ | 111,613 | $ | 143,623 | ||||||||
| Adjustments to reconcile net income to net cash | ||||||||||||
| provided by operating activities: | ||||||||||||
| Depreciation and amortization | 59,234 | 61,613 | ||||||||||
| Share-based compensation | 10,003 | 9,841 | ||||||||||
| Changes in operating assets, liabilities and other | (20,876 | ) | (22,003 | ) | ||||||||
| Net cash provided by operating activities | 159,974 | 193,074 | ||||||||||
| Cash flows from investing activities: | ||||||||||||
| Purchases of property, plant and equipment | (120,588 | ) | (87,733 | ) | ||||||||
| Purchases of short-term investments | (96,571 | ) | (100,558 | ) | ||||||||
| Proceeds from maturities of short-term investments | 42,148 | 44,696 | ||||||||||
| Government incentives | 1,469 | 1,541 | ||||||||||
| Other | (57 | ) | (4 | ) | ||||||||
| Net cash used in investing activities | (173,599 | ) | (142,058 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||
| Repayments of debt | (17,969 | ) | (4,500 | ) | ||||||||
| Common stock repurchases | (97,422 | ) | - | |||||||||
| Proceeds from share-based arrangements | 2,120 | 1,074 | ||||||||||
| Net settlements of restricted stock awards | (2,013 | ) | (3,002 | ) | ||||||||
| Net cash used in financing activities | (115,284 | ) | (6,428 | ) | ||||||||
| Effects of exchange rate changes on cash, cash equivalents, and restricted cash | 10,129 | (6,454 | ) | |||||||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (118,780 | ) | 38,134 | |||||||||
| Cash, cash equivalents, and restricted cash, beginning of period | 601,243 | 501,867 | ||||||||||
| Cash, cash equivalents, and restricted cash, end of period | $ | 482,463 | $ | 540,001 | ||||||||
| Reconciliation of GAAP Net income and Earnings per Share attributable to |
||||||||||||
| (in thousands, except per share amounts) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months ended | ||||||||||||
| 2025 | 2025 | 2024 | ||||||||||
| GAAP Net income attributable to |
$ | 22,891 | $ | 8,861 | $ | 34,388 | ||||||
| FX (gain) loss | 14,258 | 31,111 | (4,068 | ) | ||||||||
| Estimated tax effects of FX (gain) loss | (3,663 | ) | (8,337 | ) | 914 | |||||||
| Estimated noncontrolling interest effects of above | (4,130 | ) | (7,376 | ) | 681 | |||||||
| Non-GAAP Net income attributable to |
$ | 29,356 | $ | 24,259 | $ | 31,915 | ||||||
| Weighted-average number of common shares outstanding - Diluted | 58,068 | 60,974 | 62,414 | |||||||||
| GAAP Diluted earnings per share attributable to |
$ | 0.39 | $ | 0.15 | $ | 0.55 | ||||||
| Effects of non-GAAP adjustments above | 0.12 | 0.25 | (0.04 | ) | ||||||||
| Non-GAAP Diluted earnings per share attributable to |
$ | 0.51 | $ | 0.40 | $ | 0.51 | ||||||
For Further Information:
VP, Investor Relations
469.395.8175
tmoreau@photronics.com
Source: Photronics, Inc.




